| Product Code: ETC13103081 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Suriname market for plasma protein therapeutics saw a decline in growth rate from 2023 to 2024, with a high Herfindahl-Hirschman Index indicating increased market concentration. In 2024, top exporting countries included Peru, Netherlands, USA, Brazil, and Germany. Despite the negative growth rate in 2024, the compound annual growth rate (CAGR) from 2020 to 2024 remained positive at 2.08%. The market dynamics suggest potential challenges in market competition and future strategies for market diversification to mitigate risks associated with high concentration levels.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Plasma Protein Therapeutic Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Plasma Protein Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Plasma Protein Therapeutic Market - Industry Life Cycle |
3.4 Suriname Plasma Protein Therapeutic Market - Porter's Five Forces |
3.5 Suriname Plasma Protein Therapeutic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Plasma Protein Therapeutic Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Suriname Plasma Protein Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Suriname Plasma Protein Therapeutic Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Suriname Plasma Protein Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Plasma Protein Therapeutic Market Trends |
6 Suriname Plasma Protein Therapeutic Market, By Types |
6.1 Suriname Plasma Protein Therapeutic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Immunoglobulins, 2021 - 2031F |
6.1.4 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Albumin, 2021 - 2031F |
6.1.5 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Clotting Factors, 2021 - 2031F |
6.1.6 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Alpha-1 Antitrypsin, 2021 - 2031F |
6.1.7 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Suriname Plasma Protein Therapeutic Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Human Plasma, 2021 - 2031F |
6.2.3 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Blood Plasma, 2021 - 2031F |
6.2.4 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Factor VIII, IX, 2021 - 2031F |
6.2.5 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Genetic Plasma, 2021 - 2031F |
6.2.6 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Suriname Plasma Protein Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Hemophilia Centers, 2021 - 2031F |
6.3.5 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.3.6 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Suriname Plasma Protein Therapeutic Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Immune Deficiency Treatment, 2021 - 2031F |
6.4.3 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Liver & Kidney Disorders, 2021 - 2031F |
6.4.4 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Blood Disorder Management, 2021 - 2031F |
6.4.5 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4.6 Suriname Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
7 Suriname Plasma Protein Therapeutic Market Import-Export Trade Statistics |
7.1 Suriname Plasma Protein Therapeutic Market Export to Major Countries |
7.2 Suriname Plasma Protein Therapeutic Market Imports from Major Countries |
8 Suriname Plasma Protein Therapeutic Market Key Performance Indicators |
9 Suriname Plasma Protein Therapeutic Market - Opportunity Assessment |
9.1 Suriname Plasma Protein Therapeutic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Plasma Protein Therapeutic Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Suriname Plasma Protein Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Suriname Plasma Protein Therapeutic Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Suriname Plasma Protein Therapeutic Market - Competitive Landscape |
10.1 Suriname Plasma Protein Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Suriname Plasma Protein Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |